Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -1.08EBIT per Share
VS
Market
Sector
Industry
History
$ 1.27Close
$ 0.95 - $ 3.22 52-Week Range
Ticker Information
Ticker
ALLOCompany Name
ALLOGENE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQALLOGENE THERAPEUTICS INC - EBIT per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ALLO - EBITPS Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
|---|---|---|---|---|
| 6/30/2025 | $ -235.87M | $ -1.08 | 1 | 218.93M |
| 3/31/2025 | $ -251.55M | $ -1.17 | 1 | 215.36M |
| 12/31/2024 | $ -256.97M | $ -1.32 | 1 | 194.81M |
| 9/30/2024 | $ -286.81M | $ -1.37 | 1 | 209.19M |
| 6/30/2024 | $ -281.93M | $ -1.48 | 1 | 190.03M |
| 3/31/2024 | $ -293.56M | $ -1.74 | 1 | 169.13M |
| 12/31/2023 | $ -327.26M | $ -2.09 | 1 | 156.93M |
| 9/30/2023 | $ -332.86M | $ -1.99 | 1 | 167.65M |
| 6/30/2023 | $ -354.69M | $ -2.42 | 1 | 146.8M |
| 3/31/2023 | $ -351.49M | $ -2.43 | 1 | 144.56M |
Key Performance Insights, Last 5 Years
- ALLOGENE THERAPEUTICS INC's latest trailing twelve months (TTM) EBITPS stands at $ -1.91.
- Over the past 5 years, ALLOGENE THERAPEUTICS INC's average EBITPS has been $ -1.85.
- The median EBITPS for ALLOGENE THERAPEUTICS INC during this period was $ -1.9
- ALLOGENE THERAPEUTICS INC reached its highest EBITPS over the past 5 years at $ -1.08.
- The lowest EBITPS recorded by ALLOGENE THERAPEUTICS INC in the same timeframe $ -2.43
Similar metrics to Shares WA:
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Sales per Share - [Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of EBIT per Share
[Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].EBIT / (Shares WA * Share Factor)
(=) EBITPS EBITPS for ALLOGENE THERAPEUTICS INC is calculated as follows: EBIT [ $ -242.84M ] / (Shares WA [ 127.14M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -1.91 ] ALLO - EBIT per Share, Last 5 years
$ -2.43
Minimum
Mar 31, 2023
$ -1.08
Maximum
Jun 30, 2025
$ -1.85
Average
$ -1.9
Median
EBITPS Benchmark AnalysisMarket
The chart above depicts the distribution of EBITPS for companies in the Total Stock Market. The average EBITPS of the companies is $ 1.16 with a standard deviation of $ 3.42.
The following table provides additional summary stats:
EBITPS in the Market:
| filtered constituents | 3.79K |
|---|---|
| min | $ -9.72 |
| max | $ 10.76 |
| average | $ 1.16 |
| median | $ 0.38 |
| std | $ 3.42 |